| 2024年中报 | 2023年年报 | 2022年年报 | |
|---|---|---|---|
| 营业收入(元) | |||
| CDMO(元) | 59,198,619.72 | 153,742,916.52 | 140,300,878.14 |
| 标准肝素原料(元) | 532,521,159.44 | 997,326,413.18 | 1,109,642,038.58 |
| 制剂(元) | 1,547,734,824.15 | 2,771,665,012.18 | 2,458,169,057.43 |
| 营业成本(元) | |||
| CDMO(元) | 34,809,870.04 | 99,444,679.61 | 86,085,871.44 |
| 标准肝素原料(元) | 377,951,044.62 | 661,927,692.42 | 659,925,241.95 |
| 制剂(元) | 865,110,972.64 | 1,260,714,461.78 | 1,018,774,254.69 |
| 毛利(元) | |||
| CDMO(元) | 24,388,749.68 | 54,298,236.91 | 54,215,006.70 |
| 标准肝素原料(元) | 154,570,114.82 | 335,398,720.76 | 449,716,796.63 |
| 制剂(元) | 682,623,851.51 | 1,510,950,550.40 | 1,439,394,802.74 |
| 毛利率(%) | |||
| CDMO(%) | 41.20 | 35.32 | 38.64 |
| 标准肝素原料(%) | 29.03 | 33.63 | 40.53 |
| 制剂(%) | 44.10 | 54.51 | 58.56 |
| 收入构成(%) | |||
| CDMO(%) | 2.77 | 3.92 | 3.78 |
| 标准肝素原料(%) | 24.89 | 25.42 | 29.92 |
| 制剂(%) | 72.34 | 70.66 | 66.29 |
| 毛利构成(%) | |||
| CDMO(%) | 2.83 | 2.86 | 2.79 |
| 标准肝素原料(%) | 17.94 | 17.65 | 23.14 |
| 制剂(%) | 79.23 | 79.50 | 74.07 |